ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2015

Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence.

Aravind Sosale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.